Corporate News - Archive

| Investor News

M1 Kliniken AG (ISIN: DE000A0STSQ8) publishes preliminary figures for the financial year 2019. In the past financial year, the M1 Group further strengthened its market leadership in Germany in the field of beauty medicine and accelerated its international expansion.

| Investor News

Following the federal and state governments announcement to continue the ban on contact to at least 19/20 April 2020, M1 Kliniken AG has decided to keep its own clinics and practices closed until 24 April 2020. Internally, however, plans for the reopening have already begun.

| Ad-hoc news

The M1 Group will close all clinic and practice locations for beauty treatments from 21.03.2020. Impact of corona pandemic on sales limited so far. Offers to health authorities to use the practice infrastructure as a corona or Covid19 test centres are planned.

| Investor News

In recent years, M1 Kliniken AG (ISIN: DE000A0STSQ8) has become the leading specialist for plastic and aesthetic beauty medicine in Germany.

| Investor News

M1 Kliniken AG (ISIN: DE000A0STSQ8) continued its growth course in the first half of 2019. In the first six months of the year, Germany’s market leader in the field of beauty medicine increased sales by 14% from EUR 28.9 million to EUR 32.9 million.

| Investor News

Today the Annual General Meeting 2019 of M1 Kliniken AG (ISIN: DE000A0STSQ8) took place in Berlin. The attendance was 77 %. The shareholders approved the proposal of the Management Board and Supervisory Board to distribute a dividend of 0.30 Euro per share for the financial year 2018.

| Investor News

After M1 Kliniken AG was able to increase the number of specialist centres to 24 by the end of the year in 2018, the group has created the prerequisites for further growth in Germany and abroad. The expansion of room capacities created the basis for a significantly larger number of doctors in aesthetic medicine.

| Investor News

M1 Kliniken AG today published its consolidated financial statements for 2018. The M1 Group further expanded its market leadership in Germany in the field of beauty medicine and expanded its range of services with “M1 Laser” and “M1 Dental” to include dermatological laser and aesthetic dental treatments.

| Investor News

M1 Kliniken AG has continued its profitable growth in 2018 and invested considerably in further expansion. In the 2018 financial year, the M1 Group increased sales by a good 38% year-on-year to EUR 65.2 million (preliminary figures). Despite the start-up costs of the numerous new locations profit increased in 2018.

| Investor News

M1 Kliniken AG (ISIN: DE000A0STSQ8) is driving growth in the field of medical cosmetic products. Under its own brand M1 SELECT, the beauty medicine specialist has been offering a selected range of high-quality active cosmetics with a focus on skin and facial care since December 2017.